Aberrant epigenetic silencing of neuronatin is a frequent event in human osteosarcoma.
Saeed H, Sinha S, Mella C, Kuerbitz JS, Cales ML, Steele MA, Stanke J, Damron D, Safadi F, Kuerbitz SJ.
Saeed H, et al. Among authors: kuerbitz sj.
Oncotarget. 2020 May 19;11(20):1876-1893. doi: 10.18632/oncotarget.27583. eCollection 2020 May 19.
Oncotarget. 2020.
PMID: 32499872
Free PMC article.